{"id":"NCT00866606","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects","officialTitle":"An Evaluation Of The Safety And Efficacy Of On-Demand Treatment With BeneFIX (Nonacog Alfa, Recombinant Factor IX) In Chinese Subjects With Hemophilia B","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2009-12","completion":"2009-12","firstPosted":"2009-03-20","resultsPosted":"2011-01-04","lastUpdate":"2011-04-05"},"enrollment":35,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia B"],"interventions":[{"type":"BIOLOGICAL","name":"Benefix","otherNames":[]}],"arms":[{"label":"Benefix","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the safety and efficacy of on-demand treatment with BeneFIX in Chinese hemophilia B subjects.","primaryOutcome":{"measure":"Investigator Hemostatic Efficacy Assessment of Participants After 8 Hours Post Infusion","timeFrame":"8 hours post infusion","effectByArm":[{"arm":"BeneFactor IX (BeneFIX)","deltaMin":1.7,"sd":0.72}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":6,"countries":["China"]},"refs":{"pmids":["22776196"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=3090A1-3305&StudyName=Study%20Evaluating%20On-Demand%20Treatment%20With%20BeneFIX%20In%20Chinese%20Subjects"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":35},"commonTop":["Anemia","Inflammation","Injury","Joint Sprain","Abdominal pain"]}}